特拉贝克丁在骨肉瘤模型中促进瘤性病毒抗瘤疗效,病毒基因表达和免疫效应器功能
Emily M Ringwalt1,2, Mark A Currier1, Andrea M Glaspell1
1Center for Childhood Cancer Research, Nationwide Children's Hospital, Columbus, OH 43215, USA.
Molecular therapy. Oncology
|November 4, 2024
概括
特拉贝克丁通过破坏抗病毒反应和减少免疫抑制细胞来增强瘤性简单疹病毒免疫疗法. 这种组合疗法通过直接杀死病毒和增强细胞毒性淋巴细胞活性促进免疫介导的瘤回归.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 特拉贝克丁是一种DNA基剂,此前曾与瘤性病毒免疫疗法显示出协同作用.
- 这种协同作用的基本机制尚未完全理解.
研究的目的:
- 阐明特拉贝克丁增强性简单疹病毒免疫疗法的机制.
- 为了评估trabectedin增强型病毒免疫疗法的有效性,在突发性小鼠肉瘤模型中.
主要方法:
- 研究了trabectedin对人类肉瘤细胞中细胞抗病毒反应的影响.
- 在治疗后评估病毒转录水平.
- 评估了用trabectedin和型病毒治疗的突发性小鼠肉瘤模型中的瘤回归和免疫细胞透.
主要成果:
- 特拉贝克泰丁破坏了细胞内在的抗病毒反应,增加了病毒转录的存在.
- 在小鼠模型中,trabectedin通过减少免疫抑制性CD4 T和髓质细胞来增强病毒免疫疗法.
- 特拉贝克丁刺激了瘤透的T细胞和自然杀手细胞中的花粉酶表达,导致免疫介导的回归.
结论:
- 特拉贝克泰丁通过双重机制增强瘤性病毒免疫疗法:直接杀死瘤细胞和免疫激活.
- 这些发现支持结合特拉贝克丁与瘤性简单疹病毒治疗的临床转化.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K


